MicroPort CardioFlow Medtech Corp. (HK:2160)
:2160
Want to see HK:2160 full AI Analyst Report?
Total Valuation
MicroPort CardioFlow Medtech Corp. has a market cap or net worth of HK$1.91B. The enterprise value is HK$450.53M.
Market CapHK$1.91B
Enterprise ValueHK$450.53M
Share Statistics
MicroPort CardioFlow Medtech Corp. has 1,273,311,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,273,311,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MicroPort CardioFlow Medtech Corp.’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -2.38%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-2.38%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee1.03M
Profits Per Employee-326.42K
Employee Count430
Asset Turnover0.09
Inventory Turnover0.23
Valuation Ratios
The current PE Ratio of MicroPort CardioFlow Medtech Corp. is ―. MicroPort CardioFlow Medtech Corp.’s PEG ratio is -0.11.
PE Ratio―
PS Ratio6.71
PB Ratio1.49
Price to Fair Value1.49
Price to FCF-10.00
Price to Operating Cash Flow-5.64
PEG Ratio-0.11
Income Statement
In the last 12 months, MicroPort CardioFlow Medtech Corp. had revenue of 443.79M and earned -146.41M in profits. Earnings per share was -0.30.
Revenue443.79M
Gross Profit288.34M
Operating Income-101.09M
Pretax Income-140.31M
Net Income-146.41M
EBITDA-111.57M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was -25.52M and capital expenditures -518.92M, giving a free cash flow of -544.44M billion.
Operating Cash Flow-25.52M
Free Cash Flow-544.44M
Free Cash Flow per Share-0.43
Dividends & Yields
MicroPort CardioFlow Medtech Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.90
52-Week Price Change-70.98%
50-Day Moving Average2.30
200-Day Moving Average4.74
Relative Strength Index (RSI)15.91
Average Volume (3m)8.07M
Important Dates
MicroPort CardioFlow Medtech Corp. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateApr 2, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
MicroPort CardioFlow Medtech Corp. as a current ratio of 2.52, with Debt / Equity ratio of 12.96%
Current Ratio2.52
Quick Ratio1.93
Debt to Market Cap0.54
Net Debt to EBITDA-11.35
Interest Coverage Ratio-59.12
Taxes
In the past 12 months, MicroPort CardioFlow Medtech Corp. has paid 6.14M in taxes.
Income Tax6.14M
Effective Tax Rate-0.04
Enterprise Valuation
MicroPort CardioFlow Medtech Corp. EV to EBITDA ratio is -38.03, with an EV/FCF ratio of -14.25.
EV to Sales9.56
EV to EBITDA-38.03
EV to Free Cash Flow-14.25
EV to Operating Cash Flow-164.32
Balance Sheet
MicroPort CardioFlow Medtech Corp. has HK$1.38B in cash and marketable securities with HK$258.36M in debt, giving a net cash position of HK$1.12B billion.
Cash & Marketable SecuritiesHK$1.38B
Total DebtHK$258.36M
Net CashHK$1.12B
Net Cash Per ShareHK$0.88
Tangible Book Value Per ShareHK$1.80
Margins
Gross margin is 53.85%, with operating margin of -22.78%, and net profit margin of -32.99%.
Gross Margin53.85%
Operating Margin-22.78%
Pretax Margin-31.62%
Net Profit Margin-32.99%
EBITDA Margin-25.14%
EBIT Margin-34.51%
Analyst Forecast
The average price target for MicroPort CardioFlow Medtech Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-4.38%
EPS Growth Forecast―